Enilconazole for Conures: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Enilconazole is an imidazole antifungal medication. In birds, it is used most often as a nebulized treatment and less commonly by direct intratracheal administration performed by an experienced avian veterinarian. It is not a routine at-home medication for pet parents to start on their own.

For conures, enilconazole is usually discussed when your vet is concerned about fungal respiratory disease, especially aspergillosis. Aspergillus spores are common in the environment, and birds can develop disease when spores settle in the lungs or air sacs. Conures with breathing changes, voice changes, tail bobbing, reduced activity, or weight loss need prompt veterinary evaluation because fungal disease can look like many other problems.

This medication is considered extra-label in pet birds in the United States, which means your vet may use it based on avian references and clinical judgment rather than a bird-specific FDA label. That is common in avian medicine. The exact plan depends on where the infection is located, how sick your bird is, and whether your vet is combining enilconazole with other antifungals, oxygen support, imaging, or hospitalization.

In conures, enilconazole is used mainly as part of treatment for aspergillosis, a fungal infection that often affects the lungs, air sacs, sinuses, or trachea. Your vet may consider it when a bird has respiratory signs and testing supports a fungal cause, or when aspergillosis is strongly suspected based on exam findings, imaging, endoscopy, or cytology.

It is usually not the only treatment. Many birds need a broader plan that may include systemic antifungals such as itraconazole, voriconazole, or other medications chosen by your vet, along with supportive care like heat support, oxygen, fluids, nutritional help, and treatment of any secondary bacterial infection if present.

Enilconazole may also be chosen because nebulization can deliver medication directly to the respiratory tract. That can be helpful in birds with air sac disease or fungal plaques, although response varies by case. Some birds improve with a combined approach, while others need more advanced diagnostics or procedures to remove obstructive fungal material.

There is no one-size-fits-all dose for conures. Avian dosing is usually calculated by body weight and adjusted for the route used, the severity of disease, and how well the bird tolerates treatment. In veterinary references for pet birds, enilconazole has been listed as 0.1 mL/kg in 5 mL sterile water by nebulization for 30 minutes, typically on a 5-days-on/2-days-off schedule, and also as 1 mg total, equivalent to 0.05 mL/kg of a 1:10 dilution, given intratracheally once daily for 7-14 days. These are reference doses, not instructions for home use.

For a small conure, even tiny measuring errors can matter. Nebulizer type, chamber size, dilution, ventilation, and treatment length all affect how much medication actually reaches the respiratory tract. Intratracheal dosing should only be done by your vet because incorrect placement or aspiration can be dangerous.

If your vet prescribes nebulization at home, ask for the exact concentration, dilution steps, chamber setup, session length, and cleaning instructions in writing. Do not substitute human antifungal products or change the dilution on your own. If your conure becomes more distressed during treatment, stops perching, breathes with an open mouth, or seems weaker, stop and contact your vet right away.

Bird-specific side effect data for enilconazole are limited, so your vet will usually monitor closely and balance potential benefit against risk. The most important concern is respiratory irritation during or after nebulization. Some birds may show increased breathing effort, stress, coughing-like motions, voice changes, or reluctance to remain in the chamber.

Other possible concerns include eye or mucous membrane irritation, reduced appetite from treatment stress, and worsening weakness in birds that are already unstable. With direct airway administration, there is added risk of handling stress, aspiration, or airway trauma if the procedure is not performed correctly.

See your vet immediately if your conure has open-mouth breathing, marked tail bobbing, blue or gray discoloration, collapse, severe lethargy, or sudden refusal to eat. Those signs may reflect progression of the underlying disease, a poor response to treatment, or another emergency that needs fast reassessment.

Published interaction data for enilconazole in conures are sparse, so your vet should review every medication, supplement, disinfectant, and nebulized product your bird is receiving. That includes oral antifungals, antibiotics, anti-inflammatory drugs, bronchodilators, probiotics, and any over-the-counter cage or air treatments.

Because enilconazole is an azole antifungal, your vet may be especially thoughtful when combining it with other antifungal medications. In some cases, combination therapy is intentional and useful. In others, overlapping irritation, handling stress, or cumulative adverse effects may outweigh the benefit.

Do not mix enilconazole into a nebulizer chamber with another medication unless your vet specifically instructs you to do so. Compatibility, stability, and airway tolerance can vary. It is also important to tell your vet if your conure has liver disease, severe respiratory compromise, or a history of reacting poorly to nebulization, because those details may change the treatment plan.